Inhibition of COX-2 and PI3K/AKT Pathways to Prevent Cancer Metastasis.
作者信息
Kumar Punet, Singh Sangam
机构信息
Department of Pharmaceutical Chemistry, Shri Gopichand College of Pharmacy, Dr. A.P.J. Abdul Kalam Technical University, Baghpat, India.
Department of Pharmaceutical Chemistry, Oxford College of Pharmacy, Dr. A.P.J. Abdul Kalam Technical University, Hapur, India.
出版信息
Adv Pharm Bull. 2025 Mar 23;15(2):230-231. doi: 10.34172/apb.44038. eCollection 2025 Jul.
Abstract
摘要
相似文献
1
Inhibition of COX-2 and PI3K/AKT Pathways to Prevent Cancer Metastasis.抑制COX-2和PI3K/AKT信号通路以预防癌症转移。
Adv Pharm Bull. 2025 Mar 23;15(2):230-231. doi: 10.34172/apb.44038. eCollection 2025 Jul.
2
Ononin inhibits triple-negative breast cancer lung metastasis by targeting the EGFR-mediated PI3K/Akt/mTOR pathway.染料木黄酮通过靶向 EGFR 介导的 PI3K/Akt/mTOR 通路抑制三阴性乳腺癌肺转移。
Sci China Life Sci. 2024 Sep;67(9):1849-1866. doi: 10.1007/s11427-023-2499-2. Epub 2024 Jun 17.
3
Endogenous pAKT activity is associated with response to AKT inhibition alone and in combination with immune checkpoint inhibition in murine models of TNBC.内源性 pAKT 活性与 AKT 抑制单独和与免疫检查点抑制联合在 TNBC 小鼠模型中的反应相关。
Cancer Lett. 2024 Apr 1;586:216681. doi: 10.1016/j.canlet.2024.216681. Epub 2024 Feb 3.
4
Co-targeting PI3K/Akt and MAPK/ERK pathways leads to an enhanced antitumor effect on human hypopharyngeal squamous cell carcinoma.双重靶向 PI3K/Akt 和 MAPK/ERK 信号通路可增强人下咽鳞癌细胞的抗肿瘤作用。
J Cancer Res Clin Oncol. 2019 Dec;145(12):2921-2936. doi: 10.1007/s00432-019-03047-2. Epub 2019 Oct 16.
5
Hesperetin Inhibits Bladder Cancer Cell Proliferation and Promotes Apoptosis and Cycle Arrest by PI3K/AKT/FoxO3a and ER Stress-mitochondria Pathways.橙皮素通过PI3K/AKT/FoxO3a和内质网应激-线粒体途径抑制膀胱癌细胞增殖并促进凋亡和细胞周期阻滞。
Curr Med Chem. 2024 Feb 13. doi: 10.2174/0109298673283888231217174702.
6
Upregulated SAE1 Drives Tumorigenesis and Is Associated with Poor Clinical Outcomes in Breast Cancer.SAE1上调驱动肿瘤发生并与乳腺癌不良临床预后相关。
Breast J. 2024 Jun 30;2024:2981722. doi: 10.1155/2024/2981722. eCollection 2024.
7
Roles of JNK, ERK, and PI3K/AKT signaling pathways in zinc-mediated alleviation of thermal stress-induced damage to the integrity and barrier function of primary cultured chick jejunal epithelial cells.JNK、ERK和PI3K/AKT信号通路在锌介导减轻热应激对原代培养鸡空肠上皮细胞完整性和屏障功能损伤中的作用
J Anim Sci. 2025 Jan 4;103. doi: 10.1093/jas/skaf266.
8
Melatonin effect on breast and ovarian cancers by targeting the PI3K/Akt/mTOR pathway.褪黑素通过靶向 PI3K/Akt/mTOR 通路对乳腺癌和卵巢癌的影响。
IUBMB Life. 2024 Dec;76(12):1035-1049. doi: 10.1002/iub.2900. Epub 2024 Aug 30.
9
The effect of chloroquine on cervical cancer via the PI3K/AKT/MDM2 pathway.氯喹通过PI3K/AKT/MDM2信号通路对宫颈癌的影响。
Discov Oncol. 2025 Jun 23;16(1):1179. doi: 10.1007/s12672-025-02939-9.
10
Etomidate suppresses proliferation, migration, invasion, and glycolysis in esophageal cancer cells via PI3K/AKT pathway inhibition.依托咪酯通过抑制PI3K/AKT信号通路抑制食管癌细胞的增殖、迁移、侵袭和糖酵解。
Cytotechnology. 2025 Feb;77(1):4. doi: 10.1007/s10616-024-00661-y. Epub 2024 Nov 20.
本文引用的文献
1
Cancer stem cells: advances in knowledge and implications for cancer therapy.癌症干细胞：知识进展及其对癌症治疗的影响。
Signal Transduct Target Ther. 2024 Jul 5;9(1):170. doi: 10.1038/s41392-024-01851-y.
2
Targeting inflammation as cancer therapy.靶向炎症作为癌症治疗方法。
J Hematol Oncol. 2024 Mar 22;17(1):13. doi: 10.1186/s13045-024-01528-7.
3
Advancements in dual-target inhibitors of PI3K for tumor therapy: Clinical progress, development strategies, prospects.PI3K 双重抑制剂在肿瘤治疗中的研究进展：临床进展、研发策略、前景展望。
Eur J Med Chem. 2024 Feb 5;265:116109. doi: 10.1016/j.ejmech.2023.116109. Epub 2023 Dec 31.
4
Recent advances in targeting the "undruggable" proteins: from drug discovery to clinical trials.靶向“不可成药”蛋白的最新进展：从药物发现到临床试验。
Signal Transduct Target Ther. 2023 Sep 6;8(1):335. doi: 10.1038/s41392-023-01589-z.
5
PI3K/AKT/mTOR signaling transduction pathway and targeted therapies in cancer.PI3K/AKT/mTOR 信号转导通路与癌症的靶向治疗。
Mol Cancer. 2023 Aug 18;22(1):138. doi: 10.1186/s12943-023-01827-6.
6
Protective Effects of Long-Term Usage of Cyclo-Oxygenase-2 Inhibitors on Colorectal Cancer in Genetically Predisposed Individuals and Their Overall Effect on Prognosis: A Systematic Review.长期使用环氧化酶-2抑制剂对遗传易感性个体结直肠癌的保护作用及其对预后的总体影响：一项系统评价
Cureus. 2023 Jul 15;15(7):e41939. doi: 10.7759/cureus.41939. eCollection 2023 Jul.
7
The PI3K-Akt-mTOR and Associated Signaling Pathways as Molecular Drivers of Immune-Mediated Inflammatory Skin Diseases: Update on Therapeutic Strategy Using Natural and Synthetic Compounds.PI3K-Akt-mTOR 及相关信号通路作为免疫介导性炎症性皮肤病的分子驱动因素：天然和合成化合物治疗策略的最新进展。
Cells. 2023 Jun 20;12(12):1671. doi: 10.3390/cells12121671.
8
The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth.不断演变的肿瘤微环境：从癌症起始到转移灶生长
Cancer Cell. 2023 Mar 13;41(3):374-403. doi: 10.1016/j.ccell.2023.02.016.
9
Recent progress on FAK inhibitors with dual targeting capabilities for cancer treatment.FAK 抑制剂在癌症治疗中双重靶向能力的最新进展。
Biomed Pharmacother. 2022 Jul;151:113116. doi: 10.1016/j.biopha.2022.113116. Epub 2022 May 19.
10
Chemotherapy-induced COX-2 upregulation by cancer cells defines their inflammatory properties and limits the efficacy of chemoimmunotherapy combinations.癌细胞诱导的 COX-2 上调定义了它们的炎症特性，并限制了化疗免疫治疗联合的疗效。
Nat Commun. 2022 Apr 19;13(1):2063. doi: 10.1038/s41467-022-29606-9.
Zotero 插件